Welcome to this week’s edition of the legislative roundup. With prohibitionists fighting nationwide, from Massachusetts to deny the will of the voters with the implementation of legalization to Hawaii where the state is seeking to impose increased monitoring of drivers who may be under the influence of marijuana, NORML is constantly working to fight the rising tide of anti-science legislation cropping up.
Below are the priority bills that we’ve tracked this week, with more being posted on our http://norml.org/act page every day.
If you have not yet, make sure to sign up for our email list and we will keep you posted as these bills and more move through your home state legislature and at the federal level.
Thanks for all you do,
Legislative efforts are pending to amend the state’s voter-initiated medical marijuana law in a manner that would restrict qualified patients from smoking herbal preparations of the plant. Republican Gov. Asa Hutchinson indicates that he favors the plan.
NORML opposes this effort to fundamentally change the law for the following reasons.
The inhalation of herbal cannabis is associated with the rapid onset of drug effect while the oral consumption of other preparations, such as oils, extracts, or pills, is associated with significantly delayed onset. For patients seeking rapid relief from symptoms, such as those suffering from severe nausea, seizures, or spasms, inhaling herbal cannabis is the fastest and most effective route of administration. Inhaling cannabis also permits patients to better regulate their dose.
Further, the effects of orally ingested cannabis are far less predictable in comparison to inhaled cannabis. This is because there exists far greater variability in the ways that marijuana is metabolized when it is consumed orally — meaning that patients may experience disparate and even dysphoric effects from dose to dose, even in instances where the dose is standardized.
Additionally, SB 130 prohibits individuals from operating a motor vehicle if they have 5 or more nanograms of THC per milliliter in their blood. NORML opposes this proposal.
It should not be presumed that the detection of THC is predictive of psychomotor impairment and such a presumption should not be codified in Arkansas traffic safety statutes. The imposition and enforcement of this measure risks inappropriately convicting unimpaired subjects of traffic safety violations.
Legislation is pending, SB 548, to legalize the possession and use of limited amounts of marijuana for those over the age of 21.
According to 2014 statewide poll, 66 percent of Hawaii voters support the taxation and regulation of marijuana.
Additionally, Legislation is pending, SB 17, that seeks to establish a per se limit of “five nanograms or more per milliliter of active tetrahydrocannabinol” for anyone driving a motor vehicle.
NORML opposes this proposal.
It should not be presumed that the detection of THC is predictive of psychomotor impairment and such a presumption should not be codified in Hawaii traffic safety statutes. The imposition and enforcement of this measure risks inappropriately convicting unimpaired subjects of traffic safety violations.
On Wednesday, December 28, a handful of lawmakers met in a special session and voted to delay the roll out of retail marijuana providers from January 1, 2018 to July 1, 2018. As summarized by The Boston Globe, “The extraordinary move, made in informal sessions with just a half-dozen legislators present, would unravel a significant part of the legalization measure passed by 1.8 million voters just last month.” Governor Charlie Baker signed the bill into law just two days later.
But this was only the beginning.
Now, Senator Jason M. Lewis is proposing bills that would reduce the amount of marijuana that an individual can possess, restrict the number of plants that a person can grow, and ban various forms of THC infused products including edibles.
The arrogance and hubris lawmakers are showing toward voters is shocking, and is typified by the comments of Senate President Stanley C. Rosenberg who, only hours after the vote, pronounced: “I believe that when voters vote on most ballot questions, they are voting in principle. They are not voting on the fine detail that is contained within the proposal.”
It’s time for you to send another clear message to your lawmakers: Abide by voters’ decision or suffer the consequences.
State Senator Anna Wishart has introduced comprehensive medical marijuana legislation, LB622.
Senator Wishart’s bill is similar to legislation that was introduced in 2016 and narrowly defeated. LB622 will allow patients with conditions such as Crohn’s disease, epilepsy, opioid addictions and some types of cancer to obtain marijuana. Additionally it would permit patients to grow up to 12 plants and/or possess up to six ounces of cannabis for therapeutic purposes. Last year’s bill was narrowly defeated by lawmakers.
Twenty-nine states and the District of Columbia have enacted statewide provisions allowing patients access to cannabis therapy. Nebraska patients deserve these same protections.
After nearly a decade of frustration, 2017 may finally be the year that New Hampshire voters successfully see marijuana possession decriminalized.
HB640, sponsored by 6 Republicans and 6 Democrats, will amend criminal penalties for marijuana possession is pending in the House, where lawmakers have overwhelmingly supported such efforts for eight years in a row. However, legislators this year are hopeful that, for the first time, they also have sufficient votes to also clear the Senate.
Additionally, Multiple bills are pending before lawmakers to expand the pool of patients eligible to qualify for medical marijuana therapy.
In particular, these measures would permit patients with conditions like chronic pain and post-traumatic stress to obtain legal access to marijuana.
Most recently, an exhaustive report released by the National Academies of Sciences determined that there is “conclusive” evidence that cannabis is “effective for the treatment of chronic pain.” Authors concluded, “In adults with chronic pain, patients who were treated with cannabis or cannabinoids (constituents found organically in the marijuana plant) are more likely to experience a clinically significant reduction of pain symptoms.”
Senator Liz Krueger (D) has introduced the Marijuana Regulation and Taxation Act in the New York General Legislature.
The act legalizes possession and cultivation, and would establish a market for legal marijuana for adults 21 and older.
Legislation is pending, HB 1340, in the statehouse to decriminalize the possession of marijuana and marijuana-related paraphernalia.
Under existing law, marijuana possession of one ounce or less is punishable by up to 30 days in jail and a $1,500 fine, while the possession of greater amounts are classified as a felony offense punishable by up to five years in prison. Possessing marijuana-related paraphernalia is punishable by up to one year in jail and a $3,000 fine.
UPDATE: SB1091 has passed the full Senate by a vote of 38-2 and HB 2051 has passed it’s first committee vote in the House of Delegates.
State Senators Adam Ebbin (D), Bill Stanley (R) and Delegate Les Adams (R) have introduced SB 1091 and HB 2051 respectively, legislation that would remove the mandatory driver’s license suspension currently imposed for those with a marijuana possession conviction.
Under current law, any drug conviction, regardless of whether or not a motor vehicle was involved, results in an automatic suspension of the individual’s driving privileges for 6 months.
Additionally, SB 1298 has cleared the Senate Courts of Justice Committee on a 9-4 vote as it seeks to establish affirmative defense for possession of cannabidiol if an individual has written certification that they require the substance due to an approved medical condition.
Affirmative defense establishes a basic set of facts surrounding cannabidiol possession cases. If someone with a qualifying medical condition is caught possessing marijuana, an affirmative defense for the individual would likely result in a more lenient punishment.
UPDATE: HB 1212 has passed committee, making it the first piece of legislation for home cultivation in Washington state history.
Legislation is pending before the House, HB 1094 and HB 1212, to prohibit employers from discriminating against patients who legally consume marijuana during non-work hours.
The bill amends existing law so that: “An employer may not refuse to hire a qualifying patient, discharge or bar a qualifying patient from employment, or discriminate against a qualifying patient in compensation or in other terms and conditions of employment because of the qualifying patient’s: (i) Status as a qualifying patient; or (ii) Positive drug test for marijuana components or metabolites.”
Changes in the legal status of marijuana has not been associated with any adverse changes in workplace safety. In fact, a pair of studies from 2016 find that legalization is associated with greater workforce participation and with fewer workplace absences. Most recently, the National Academies of Sciences just-released marijuana and health report found “insufficient evidence” to support an association between cannabis use and occupational accidents or injuries.
On the heels of the 2016 election – where four states voted to approve adult-use marijuana initiatives, and four more voted to approve medical marijuana initiatives – NORML Chapters across the country are lobbying their state legislators for additional reforms. In the coming weeks, NORML Chapters around the country, such as California NORML, Connecticut NORML, Wyoming NORML, and Virginia NORML, will be focusing their time and energy in support of dozens of statewide reform bills seeking to amend various aspects of their state’s marijuana policies.
To help increase the likelihood of success for these volunteer-led lobbying efforts, NORML has created a citizen lobby guide. This comprehensive booklet will assist activists in planning and execution of a successful lobby day. It also provides organizational checklists and a legislative questionnaire so that marijuana activists, regardless of the state they’re located in, will be fully prepared to meet with state lawmakers to discuss meaningful marijuana law reforms and to most effectively communicate NORML’s message of ending the prohibition of marijuana on the local, state and federal level.
Citizen Lobby Guide: http://norml.org/pdf_files/NORML_CitizenLobbyGuide.pdf
In addition to offering support through NORML’s Citizen Lobby Guide, we have created more than 30 action alerts targeting state lawmakers across the country urging their support for marijuana legislation being considered in their state. Simply click on the link below and enter your information to join the fight!
Take Action: http://norml.org/act
We hope that with these tools, along with the direct support of NORML staff, marijuana activists will have the resources needed to effectively lobby state lawmakers in support of marijuana law reforms.
Here’s a list of scheduled NORML Chapter Lobby Days below:
- Virginia NORML – Jan 30
- Arizona NORML – Feb 2
- Texas NORML – Feb 8
- Houston NORML – Feb 8
- DFW NORML – Feb 8
- Waco NORML – Feb 8
- New Mexico – Feb 21
- Missouri NORML – Feb 28
- Kansas City NORML – Feb 28
- Greater St. Louis NORML – Feb 28
- Mid-Missouri NORML – Feb 28
- Springfield NORML – Feb 28
- University of Missouri NORML – Feb 28
- North Carolina NORML – Mar 1
- Charlotte NORML – Mar 1
- Denver NORML – Mar 7
- Colorado NORML – Mar 7
- Monterey County NORML – Mar 7
- NORML Women of Washington – Mar 7
- Washington NORML – Mar 7
- Portland NORML – Mar 7
- Michigan NORML – March 30
- Illinois NORML – May 17
- California NORML – June 5
To get involved or to find out more information about a lobby day in your state, please email: KevinM@NORML.org.
Since its founding, NORML has advocated that statewide legalization efforts – whether through a ballot initiative or using the legislative process – should ideally include provisions that permit and protect the act of home cultivation by marijuana consumers. This advocacy has resulted in more than 16 states now allowing home cultivation, including in six of the eight voter-initiated measures passed in 2016.
But although there has been a tremendous amount of progress on this issue, it appears that home cultivation is now at risk in several municipalities across Colorado and California. Local and state lawmakers in both jurisdictions are revisiting the issue and are moving toward unnecessarily limiting adult’s home cultivation rights.
Most recently, representatives with Denver’s Office of Marijuana Policy revealed a plan to, “limit unlicensed recreational and medical grows in private residences,” throughout the city of Denver. This decision came after months of closed-door meetings between regulators and leading marijuana industry interests such as the Marijuana Industry Group (MIG); which together, form what’s being called the, “Non-Licensed Marijuana Grows Inspection Team.”
Although there has been little to no mention of specific details regarding this proposed program, many are anticipating the new regulations to resemble those that have come under fire in Indian Wells, California. In that city, lawmakers are pushing for regulations mandating that anyone who wishes to cultivate marijuana in their home must purchase an annual permit and must also allow inspectors into their residence. This amounts to an absolutely unnecessary burden for responsible, law-abiding citizens.
In recent days, Denver NORML became inundated with emails, messages and comments on social media demanding a response to what many believe is a blatant overreach by city government officials. In response, members of Denver NORML, led by Executive Director, Jordan Person, began mobilizing volunteers to contact members of the Denver City Council with the goal of defending the rights and privacy of marijuana consumers in the city of Denver.
“With all of the uncertainty we are expecting in 2017 at both the local and state level our goal at Denver NORML is to help maintain our rights as residents of Colorado to grow in our homes,” said Person. “We will keep our members and supporters informed and part of the conversation as it happens.”
While it’s obvious that there’s a tremendous amount of work that goes into regulating Colorado’s legal marijuana industry, most marijuana consumers would never support any effort that would attempt to bring similar regulations into the privacy of their homes. Not to mention the fact that the creation of a task force or any other bureaucratic process to approve and/or oversee the cultivation of marijuana in a private residence amounts to a severe misuse of tax dollars and violation of privacy when those limited resources could be dedicated to combating actual problems in our communities.
Without providing any data points related to the correlation between home cultivation and out-of-state diversion, those advocating for tighter regulations deserve to fail in their attempt to convince marijuana consumers that allowing regular visits from government officials in their homes is a good idea. Adults who brew their own beer are not subject to inspections by the state and neither should those who choose to grow personal use quantities of marijuana. Furthermore, criminalizing the personal cultivation of marijuana is an arbitrary prohibition that has absolutely no basis in public safety. Therefore NORML will continue to support the right of individuals to grow their own marijuana as an alternative to purchasing it from licensed commercial producers.
To join the fight to protect home cultivation, check out NORML’s action page by visiting http://norml.org/act or for more information, please email Chapters@NORML.org.
According to the Associated Press, voters in Florida approved Amendment 2, an expansive medical marijuana law. The AP’s is reporting a final vote count of 71 percent to 29 percent. The Amendment required over 60 percent of the vote to become law.
“The overwhelming majority of Floridians, like voters nationwide, believe that patients ought to have the legal option to choose marijuana therapy as an alternative to conventional, and often dangerous, pharmaceuticals,” said NORML Deputy Director Paul Armentano. “With this historic vote, we can expect to see similar programs acknowledging the safety and efficacy of medical cannabis begin to take hold in the southeastern region of the United States.”
Amendment 2 amends the Florida state constitution so that qualified patients who possess a physician’s recommendation may legally possess and obtain medical cannabis provided by state licensed dispensaries. Under the law, a “debilitating medical condition” for which marijuana may be recommended includes is defined as “cancer, epilepsy, glaucoma, positive status for human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), post-traumatic stress disorder (PTSD), amyotrophic lateral sclerosis (ALS), Crohn’s disease, Parkinson’s disease, multiple sclerosis, or other debilitating medical conditions of the same kind or class as or comparable to those enumerated, and for which a physician believes that the medical use of marijuana would likely outweigh the potential health risks for a patient.” The home cultivation of cannabis is not permitted under the law.
Existing Florida law restricted limited qualifying patients only to high CBD strains of cannabis, unless they were terminally ill.
Department of Health regulators must begin issuing patient identification cards within nine months of the new law’s enactment. You can read the full text of Amendment 2 here.
“With broad support across all demographics, voters in Florida approved Amendment 2 by a landslide,” said Erik Altieri, NORML’s new Executive Director. “These results are a victory, not just for common sense public policy, but for patients all across the state who will now have access to a safe, effective treatment for a number of debilitating ailments.”
Today is National Voter Registration Day and we are pleased to present this valuable voter education tool to the marijuana movement: NORML’s updated and revised 2016 Congressional Scorecard. The Scorecard is an all-encompassing database that assigns a letter grade of ‘A’ (the highest grade possible) to ‘F’ (the lowest grade possible) to members of Congress based on their comments and voting records on matters specific to marijuana policy.
Of the 535 members of the 114th Congress:
- 330 members (62%) received a passing grade of ‘C’ or higher (270 Representatives and 60 Senators)
- Of these, 22 members (4%) received a grade of ‘A’ (20 Representatives and 2 Senators)
- 254 members (47%) received a ‘B’ grade (218 Representatives and 36 Senators)
- 54 members (10%) received a ‘C’ grade (32 Representatives and 22 Senators)
- 172 members (32%) received a ‘D’ grade (149 Representatives and 23 Senators)
- 32 members (6%) received a failing grade (16 Representatives and 16 Senators)
- 60 Senators (60%) received a passing grade of a C or higher (Two A’s, 36 B’s, and 22 C’s)
- 270 Representatives (62%) received a passing grade of a C or higher (20 A’s, 218 B’s, and 32 C’s)
- Of the 233 Democrats in Congress, 215 (92%) received a passing grade of a ‘C’ or higher
- Of the 302 Republicans in Congress, 113 members (37%) received a passing grade of ‘C’ or higher
This analysis affirms that voters’ views on marijuana policy are well ahead of many of their federally elected officials. While the majority of Americans support legalizing the use and sale of cannabis for adults, only four percent of Congressional members voice support for this position. Approximately half (51%) of federal lawmakers favor liberalizing medical cannabis policies. However, this percentage remains far below the level of support frequently expressed by voters in state and national polls.
Also evident is that Congressional support for marijuana law reform is largely a partisan issue. While more than nine out of ten Democrats express support for some level of reform, just over one-third of Republicans hold similar positions. This partisanship lies in contrast to voters’ sentiments, which tend to view the subject as a non-partisan issue. For example, recent polls from swing states show that super-majorities of Democrats, Republicans, and Independents endorse medical marijuana legalization. Further, most Republican voters embrace principles of federalism with regard to cannabis policy. Nonetheless, Republican support for this position remains marginal among members of Congress.
HOW NORML’S CONGRESSIONAL SCORECARD IS CALCULATED
- An ‘A’ letter grade indicates that this member has publicly declared his/her support for the legalization and regulation of marijuana for adults.
- A ‘B’ letter grade indicates that this member supports policies specific to the legalization of medical cannabis and/or the decriminalization of cannabis.
- A ‘C’ letter grade indicates that this member has publicly declared his/her support for the ability of a state to move forward with cannabis law reform policies free from federal interference.
- A ‘D’ letter grade indicates that this member has expressed no support for any significant marijuana law reform
- An ‘F’ letter grade indicates that this member expresses significant and vocal opposition to marijuana law reform
FOR MORE INFORMATION
To find NORML’s grade for a specific member of Congress, please click here for the Senate scorecard and click here for the House scorecard. NORML’s full 2016 Congressional Scorecard and Executive Summary is available online here.